Balyasny Asset Management L.P.
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1218710
Chicago, IL
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,804,163
-$4,260,821 QoQ
Shares Held
309,682
-38.0% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#38
of 266 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. KNSA ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
277,821 | $30,821,461 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
309,682 | $19,804,163 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
702,858 | $17,227,049 | |
| 4 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
684,974 | $12,302,133 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
511,336 | $8,196,716 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
218,958 | $7,591,273 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
434,132 | $7,514,824 | |
| 8 | ALKS |
Alkermes plc.
|
142,366 | $7,459,978 |
All Filings in KNSA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,804,163 | 309,682 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,064,984 | 499,792 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $297,014 | 13,373 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $255,577 | 12,921 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||